Menu

Institute for Stem Cell Science and Regenerative Medicine, Bengaluru

Overview

The Institute for Stem Cell Science and Regenerative Medicine (inStem) is an Indian research organisation dedicated to stem cell science and regenerative medicine. Located in Bangalore, Karnataka, it operates as an autonomous institution under the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India.

Established in 2009, inStem pursues research aimed at developing cellular therapies for conditions including cancer, cardiovascular diseases, and neurodegenerative diseases. Its work centres on stem cell biology, human disease models, and regenerative medicine technologies.

Key details

Name Institute for Stem Cell Science and Regenerative Medicine (inStem)
Established 2009
Location Bangalore, Karnataka, India
Type Autonomous research institution
Affiliation Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India
Focus areas Stem cell science, regenerative medicine

What readers should know

  • inStem is a dedicated research organisation rather than a teaching university, with its mandate focused on stem cell and regenerative medicine research.
  • It functions under the Department of Biotechnology, placing it within the Government of India's network of autonomous scientific institutions.
  • The institute's research priorities include cellular therapies aimed at cancer, cardiovascular diseases, and neurodegenerative conditions.
  • Its scientific programmes draw on stem cell biology, human disease models, and regenerative medicine technologies.

Background

inStem was set up in 2009 in Bangalore as part of efforts by the Department of Biotechnology to build national capacity in stem cell research and regenerative medicine. As an autonomous body, it conducts research with the broader objective of translating insights from stem cell biology into therapeutic applications, including the development of cellular therapies for major disease categories.

References

Comments

0 comments

No comments yet.